28th Annual Vanderbilt Neurology Stroke and Neuroscience Symposium

In-Person and Virtual Registration

Medicine, Hearing and Speech Sciences, Neurological Surgery, Neurology, Physical Medicine & Rehabilitation, Radiology and Radiological Sciences, Surgery

The 28th Annual Vanderbilt Neurology Stroke and Neuroscience Symposium is the premiere Continuing Medical Education event aimed at improving stroke care in Middle Tennessee. The event will feature a superb lineup of local and internationally recognized leaders in stroke care. Stroke care is evolving rapidly and it is essential that changes in guidelines and in the standard of practice are efficiently communicated. Our panel of speakers will provide updates on a broad range of topics related to acute stroke care, risk factor management and prevention strategies and rehabilitation, emphasizing new guidelines, clinical trial results and identifying areas of expected growth in the field in the coming years.

Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt University Medical Center designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Optimize the management of carotid artery disease, especially asymptomatic moderate carotid artery disease.
• Identify and apply key updates to the stroke management guidelines.
• Understand key clinical trial results from the prior year.
• Appropriately assess and use published results from large observation data sources as it relates to stroke management.

We are pleased to welcome two keynote speakers:

• James Meschia, MD with Mayo Clinic
• Brian Mac Grory, MB BCh, BAO, MHSc, MRCP, FAHA, FANA with Duke University

7:50-8 a.m. Welcome

8-8:30 a.m. What Does Surgical Management of ICH Look Like One Year After the ENRICH Trial?: Matt Fusco, MD, Vanderbilt Neurosurgery

8:30-9 a.m. Hypertension and Stroke Risk, Hypertensive Emergencies: James Luther, MD, Vanderbilt Nephrology

9-9:40 a.m. Year in Review: New Clinical Trial Results: Vanderbilt Stroke Fellows, Tamer Ghanayem, MD and Anne Chatel, MD

9:40-9:50 a.m. Questions and Discussion

9:50-10 a.m. Break and Exhibits

10-10:45 a.m. What's New in the Stroke Guidelines: Deborah Kerrigan, MD, Vanderbilt Neurology

10:45-11 a.m. Stroke Survivor Story

11-11:45 a.m. Keynote Presentation: CREST2 Clinical Trial Results: James Meschia, MD, Mayo Clinic

11:45-12 p.m. Questions and Discussion

12-1 p.m. Lunch and Exhibits

1-1:45 p.m. Keynote Presentation: Incorporating Large Observational Datasets into Clinical Decision Making in Cardiovascular and Brain Health: Brian MacGrory, MB BCh, BAO, MHSc, MRCP, FAHA, FANA, Duke University

1:45-2:15 p.m. Management of Intracranial Steno-occlusive disease: Medical and Surgical Approaches: Kunal Raygor, MD, Vanderbilt Neurosurgery

2:15-2:45 p.m. Autoimmune Causes of Stroke and Approaches to Management: Olivia Gruder, MD

2:45-3:15 p.m. Topical Didactics: Cerebrovascular Surgery Fellow, Vanderbilt Neurosurgery: Lohit Velagapudi, MD

3:15-3:30 p.m. : Break and Exhibits

3:30-4 p.m. Cerebral Small Vessel Disease: Hypertension and Cerebral Amyloid Angiopathy: Matthew Schrag, MD, PhD

4-4:30 p.m. CADASIL and Hereditary Small Vessel Diseases of the Brain: James Meschia, MD

4:30-5 p.m. Cases and Posters

Exhibit opportunities are available.

If interested in an opportunity to exhibit or would like further information, please email: [email protected]